Redmile Group

Star Therapeutics raised $90M on September 5, 2023

Investors: Qatar Investment Authority, Westlake Village BioPartners®, Sofinnova Ventures, Russia technology fund, Soleus Capital Management, L.P., New Leaf Venture Partners, NYBC Ventures, OrbiMed Advisors, RA Capital Management, L.P. and Redmile Group

Sensorion raised $38M on August 3, 2023

Investors: The Invus Group, Sofinnova Partners and Redmile Group

Immunome, Inc. raised $125M on June 29, 2023

Investors: Woodline Partners LP, Avidity Partners, Enavate Sciences and Redmile Group

Krystal Biotech, Inc. raised $160M on May 21, 2023

Investors: Avoro Capital Advisors (formerly venBio Select Advisor), Braidwell and Redmile Group

Boundless Bio raised $100M on May 16, 2023

Investors: Nextech Invest, Sectoral Asset Management, Partner Fund Management, Leaps by Bayer, Surveyor Capital, Vertex Ventures HC, Logos Global Management, LP, RA Capital Management, L.P., Wellington Management and Redmile Group

Orbital Therapeutics raised $270M on April 26, 2023

Investors: Heritage Medical Systems, Newpath Partners, ARCH Venture Partners, Casdin Capital, LLC, Exor N.V., iGlobe Partners, The Invus Group and Redmile Group

Undisclosed raised $12M on April 20, 2023

Investors: Redmile Group

Saluda Medical raised $150M on April 13, 2023

Investors: Wellington Management, TPG Global and Redmile Group

Escient Pharmaceuticals raised $120M on November 28, 2022

Investors: Osage University Partners (OUP), The Column Group, Sanofi Ventures, Avego Healthcare Capital, The Eleven Fund, Partner Fund Management and Redmile Group

Ventyx Biosciences raised $177M on September 19, 2022

Investors: Great Point Partners, Walleye Capital, Logos Global Management, LP, CaaS Capital Management, Woodline Partners LP, Vivo Capital, Driehaus Capital Management LLC and Redmile Group